{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-029119","form_type":"8-K","ticker":"EXOZ","cik":"0002010788","company_name":"EXOZYMES INC.","filed_at":"2026-06-17T21:11:23+00:00","discovered_at":"2026-06-17T21:12:00.320970+00:00","generated_at":"2026-06-17T21:12:33.868410+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"eXoZymes closes public offering raising $5.95M; over-allotment partially exercised","bullets":["Gross proceeds of ~$5.95M from 330,575 units (2 shares + 1 warrant per unit) at $18.00/unit.","Over-allotment partially exercised; 34,440 additional units sold on June 17, 2026.","Warrants exercisable at $11.24/share for 5 years, with potential reset to $0.001 if shares sold below $8.99 before June 5, 2027.","Net proceeds to support NCT development, R&D, and working capital."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-029119","json":"https://secwatch.observer/filing/0001493152-26-029119.json","markdown":"https://secwatch.observer/filing/0001493152-26-029119.md","text":"https://secwatch.observer/filing/0001493152-26-029119.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2010788/000149315226029119/0001493152-26-029119-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2010788/000149315226029119/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T21:12:33.868410+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5732d2b8b7c1bf813d0982a7a9675e2ecc41092b","claim":"EXOZYMES INC. entered into Underwriting Agreement with Public Ventures LLC doing business as MDB Capital valued at Issuance and sale of 592,270 shares of common stock and warrants to purchase up to 296,135 shares of (effective 2026-06-05).","evidence_excerpt":"eXoZymes Inc. (the “Company”) entered into an Underwriting Agreement (the “Underwriting Agreement”), dated as of June 5, 2026, with Public Ventures LLC, doing business as MDB Capital (“MDB”), as the sole underwriter and book runner, pursuant to which the Company issued and sold, in a firm commitment underwritten offering (the “Offering”), an aggregate of 592,270 shares of common stock (the “Shares”), $0.000001 par value per share (the “Common Stock”), of the Company and warrants to purchase up to an additional 296,135 shares of Common Stock (the “Warrants”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/2010788/000149315226029119/0001493152-26-029119-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"Public Ventures LLC doing business as MDB Capital"},{"label":"Value","value":"Issuance and sale of 592,270 shares of common stock and warrants to purchase up to 296,135 shares of"},{"label":"Effective","value":"2026-06-05"}],"fact_type":"material_agreement"},{"claim_id":"6e0f42b6d62226b142d4eab590aad908dfcf0125","claim":"EXOZYMES INC. entered into Warrant Agent Agreement with VStock Transfer, LLC valued at Warrants to purchase shares of Common Stock issued pursuant to the agreement. (effective 2026-06-05).","evidence_excerpt":"The Warrants were issued pursuant to a Warrant Agent Agreement (“Warrant Agent Agreement”) between the Company and VStock Transfer, LLC, as warrant agent, dated June 5, 2026.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/2010788/000149315226029119/0001493152-26-029119-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Counterparty","value":"VStock Transfer, LLC"},{"label":"Value","value":"Warrants to purchase shares of Common Stock issued pursuant to the agreement."},{"label":"Effective","value":"2026-06-05"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}